All Stories

US biotech Hookipa retracts merger plans with UK company

After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.

Feb 20, 2025 - 19:49
 0
US biotech Hookipa retracts merger plans with UK company
After announcing acquisition plans at the beginning of 2025, immunotherapeutics biotech Hookipa Pharma has decided not to buy rare disease company Poolbeg Pharma.
Read More

Tags:

Previous Article

Pullman Hotels & Resorts Marks South Indian Debut with Pullman Chennai Anna ...

Next Article

'Don't be afraid of change': Penn State Health CFO's advice ...

Related Posts

Chutes & Ladders—NIH leaders join health agency exodus

Chutes & Ladders—NIH leaders join health agency exodus

Feb 21, 2025  0

Michigan CRO buys Exploristics for its cloud-based modeling platform

Michigan CRO buys Exploristics for its cloud-based mode...

Feb 12, 2025  0

Solid Bio's stock soars as early DMD gene therapy data beat expectations

Solid Bio's stock soars as early DMD gene therapy data ...

Feb 18, 2025  0